$14.89
1.43% day before yesterday
Nasdaq, Sep 26, 10:00 pm CET
ISIN
US8292141053
Symbol
SLP

Simulations Plus, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.
Neutral
GlobeNewsWire
2 days ago
Simulations Plus Q3 miss, $67.3M loss, $77.2M impairment, cut guidance; announced restructuring. Shares fell $4.50, or 25.8%, to $12.97 on Jul 15, 2025.
Neutral
GlobeNewsWire
3 days ago
SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Hagens Berman has launched an investigation into Simulations Plus, Inc. (NASDAQ: SLP) after the company's stock price plummeted approximately 25% on July 15, 2025. This sharp decline followed a series of alarming disclosures, including a massive asset impairment charge and the abrupt termination of its newly hired independent auditor, Grant Thor...
Neutral
GlobeNewsWire
4 days ago
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the federal securities laws.
Neutral
GlobeNewsWire
4 days ago
NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.
Positive
Seeking Alpha
6 days ago
Simulations Plus appears to be a unique Buy candidate, driven by an ultra-low valuation and the potential for AI-inspired growth in drug discovery modeling. The FDA Modernization Act 2.0 and industry shift away from animal testing position SLP's software and consulting for long-term relevance. Despite late 2025's expected sales growth hiccup and margin pressure, SLP's strong balance sheet and h...
Neutral
GlobeNewsWire
8 days ago
NEW YORK, Sept. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.
Neutral
GlobeNewsWire
9 days ago
SAN FRANCISCO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Hagens Berman has launched an investigation into Simulations Plus, Inc. (NASDAQ: SLP) after the company's stock price plummeted approximately 25% on July 15, 2025. This sharp decline followed a series of alarming disclosures, including a massive asset impairment charge and the abrupt termination of its newly hired independent auditor, Grant Thor...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today